Trava Health Tirzepatide Review: Cost, a BBB F Rating & Honest Verdict (2026)

Trava Health names six 503A compounding pharmacy partners — genuine transparency above the category norm — but carries a BBB F rating with two unanswered complaints, a real customer-service red flag worth weighing against the transparency positives. Every fact here comes from the company's own published program.

A BBB F rating with unanswered complaints

Worth flagging directly: Trava Health carries a BBB F rating, with its BBB file opened July 7, 2025, showing 2 unanswered complaints. This is a real, checkable customer-service signal worth weighing before committing.

What Trava Health is

Trava Health is a Houston-based DTC telehealth platform, offering compounded semaglutide+B12 and tirzepatide+B12 through six named 503A compounding pharmacy partners disclosed on its own Terms and Telehealth Consent pages. It publishes independent batch testing by Eagle Analytical, an FDA-registered lab.

What Trava Health costs

Tirzepatide starts at $198/month for the starting dose, with free overnight shipping included and no membership fee — you pay only for medication. Higher-dose pricing is gated behind the questionnaire.

The brand-vs-compounded question

Trava Health dispenses compounded semaglutide and tirzepatide, both with B12. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Trava Health's real strengths: six named compounding pharmacy partners, independent batch testing by an FDA-registered lab, free overnight shipping, no membership fee, and HSA/FSA eligibility. The trade-offs are real: a BBB F rating with 2 unanswered complaints, no LegitScript accreditation badge surfaced, a 404 clinician roster page — no public team listing, an unnamed founder/CEO, and higher-dose pricing gated behind the questionnaire rather than shown publicly. As with any GLP-1 program, and especially one with an unanswered BBB complaint history, weigh the customer-service signal against the genuine pharmacy transparency; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Trava Health's six named pharmacies and independent batch testing are real transparency strengths, but the BBB F rating with unanswered complaints is a real red flag worth weighing seriously. For a provider with a similarly transparent pharmacy network and a cleaner customer-service record, compare it against Ondra Health or Tonik Wellness. See our best tirzepatide providers ranking for the full field.